[Whole-body plethysmographic studies on the bronchospasmolytic effect of 2 antiasthmatic drug combinations and ipratropium bromide].
D000779:Anesthetics, Local / Q000627:therapeutic use*; D001286:Atropine Derivatives; D001535:Benactyzine / Q000627:therapeutic use*; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000188:drug therapy*; D002118:Calcium / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005942:Gluconates / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D010634:Phenobarbital / Q000627:therapeutic use; D010993:Plethysmography, Whole Body; D011437:Propylamines / Q000627:therapeutic use*; D013805:Theobromine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000779:Anesthetics, Local; D001286:Atropine Derivatives; D001559:Benzhydryl Compounds; D004338:Drug Combinations; D005942:Gluconates; D006634:Histamine H1 Antagonists; D010627:Phenethylamines; D011437:Propylamines; D001535:Benactyzine; D009241:Ipratropium; D013805:Theobromine; D002118:Calcium; D010634:Phenobarbital
Ganzkörperplethysmographische Untersuchungen über die bronchospasmolytische Wirkung von 2 Asthmakombinationspräparaten und ipratropiumbromid